Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Amylyx Pharmaceuticals, Inc. financial statements

Amylyx Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue087.4M380.8M22.2M285.0K650.0K1.43M
Cost of revenue05.95M25.4M2.99M52.0K24.6M11.9M
Gross profit-525.0K45.2M355.3M19.2M285.0K-23.9M-10.5M
Research and development90.4M104.1M128.2M93.5M44.0M24.6M11.9M
Selling, general and administrative62.9M114.3M188.4M127.1M38.9M14.9M3.08M
Operating income-153.3M-314.7M38.8M-201.3M-82.7M-39.0M-13.6M
Depreciation and amortization525.0K904.0K1.09M487.0K52.0K1.00K13.6M
EBITDA-152.8M-313.8M39.9M-200.9M-82.6M-39.0M0
Interest expense4.29M36.0K2.29M1.28M
Income before tax-144.7M-302.1M54.3M-197.6M-87.9M-42.3M-13.7M
Income tax46.0K-393.0K5.03M774.0K-52.0K2.56M1.10M
Net income-144.7M-301.7M49.3M-198.4M-87.9M-42.3M-14.8M
Earnings per share, basic-1.53-4.430.73-3.39-13.35-0.75-0.26
Earnings per share, diluted-1.53-4.430.70-3.39-13.35

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents226.7M77.4M170.2M62.5M50.2M12.9M3.06M
Short-term investments90.3M99.1M201.2M284.4M45.9M0
Receivables88.0K447.0K40.0M15.3M0
Inventory038.3M9.77M0
Current assets323.7M189.4M464.7M382.1M105.0M13.6M3.20M
Property, plant and equipment310.0K961.0K2.69M2.61M474.0K151.0K
Total assets332.6M193.6M517.5M391.5M105.6M14.1M3.22M
Accounts payable3.52M2.94M22.1M6.26M4.37M3.61M2.19M
Current liabilities22.7M28.4M82.0M46.6M17.4M7.33M4.53M
Long-term debt1.43M14.9M
Total debt5.96M1.98M4.24M6.28M1.43M14.9M
Total liabilities27.4M28.9M84.0M50.8M17.4M80.8M28.6M
Shareholders' equity305.3M164.8M433.4M340.6M-151.2M-66.7M-25.4M
Shares outstanding109.9M68.6M67.7M66.5M7.02M56.5M56.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-123.3M-167.6M11.9M-179.9M-74.8M-36.7M-10.7M
Capital spending-138.0K-157.0K-1.24M-2.53M-353.0K-151.0K-151.0K
Free cash flow-123.5M-167.8M10.7M-182.4M-75.2M-36.8M-10.7M
Cash from investing14.0M75.7M92.1M-239.0M-46.4M-151.0K-151.0K
Cash from financing257.0M348.0K3.54M431.8M158.5M46.8M668.0K
Share buybacks-3.31M434.6M
Change in cash148.8M-92.1M107.7M12.9M37.3M9.97M3.09M